Veralto Corporation (VLTO) | The Buildout — AI Infrastructure
The Verdict
Veralto makes water-quality instruments, chemical treatment programs, UV disinfection systems, and product-inspection and packaging software. Its link to the AI buildout runs through industrial water treatment for data-center cooling and the power, mining, and semiconductor ecosystem that feeds it, plus AI-enabled inspection and traceability software embedded in packaging workflows.
| Market Cap | — |
| Revenue (TTM) | $5.7B |
| Revenue Growth | +6.2% |
| EBITDA Margin (TTM) | 24.1% |
| Net Debt | $1.3B |
| Earnings Beats | 7 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- 60% of company revenue is recurring, per management.
- About 50% of Water Quality revenue comes from industrial applications, mostly in North America.
- Q2 core sales growth was 4.2%, and H2 2026 is guided to approximately 5%–6% volume-led.
- Cost optimization targets $65–$75 million of annual savings by 2028, on top of a 30–35% fall-through.
- Trojan UV bookings are expected to ship largely in Q4 2027, a long-cycle visibility signal.
What We’re Watching
- China Water Quality was down low single digits in Q1 on municipal funding delays; no recovery timeline is committed.
- PQI packaging and color was down high single digits in Q1; the H2 recovery leans on better funnels and an easier Q4 comp.
- Q2 margin included roughly $16 million of one-time tariff refunds, about 110 basis points, with no repeat in H2 guidance.
- Cost optimization execution risk runs through end of 2028, and the dollar savings run-rate is undisclosed.
The core thesis is strengthening: core growth accelerated sequentially, full-year EPS guidance was raised twice, and the H2 plan is explicitly volume-led. The key open question is whether the small, undisclosed data-center and PQI AI exposures become material enough to shift the company's growth algorithm, or whether the story stays a mid-single-digit quality compounder with a margin step-change in 2027–2028.
Earnings Beat
Q2 2026 revenue was $1,474 million, gross margin was 61.2%, and total sales grew 7.6% year over year. Core sales growth accelerated to 4.2% (Water Quality 5.7%, PQI 2.0%), and adjusted EPS rose 19.4%.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.4B | +7.5% |
| Gross margin | 61.2% | 60.1% | 60.0% | +120bps |
| EBITDA | $344M | $349M | $332M | +3.6% |
| EPS | $0.98 | $1.02 | $0.89 | +10.4% |
| Core sales growth | 4.2% | 1.9% | n/a | — |
In water, our industrial market demand continues to be strong. And this is really on the back of the data center demand and the associated ecosystem there, including power, mining and semiconductor.— Jennifer Honeycutt, Chief Executive Officer, July 29, 2026
Management tone: Management's tone on the Q2 call was confident and upbeat, describing the first half as accelerating growth, optimizing cost and executing disciplined capital allocation. It raised guidance again and answered tariff, pricing, and high-growth-market questions directly, while declining to size data-center revenue.
Management Guidance
For FY2026, management raised adjusted EPS guidance to $4.35–$4.43, representing 12%–14% growth. H2 core sales growth is guided to approximately 5%–6%, volume-led, with pricing at or slightly above the high end of the 100–200 bps range. Margin expansion is guided to roughly 25 bps in Q3, 25–50 bps for the full year, and north of 50 bps in Q4 led by PQI. No further tariff refunds are included in H2 guidance.
Trajectory
Revenue is steady to modestly improving: Q2 2026 revenue of $1,474 million rose 3.7% sequentially, and core growth accelerated to 4.2%. Gross margin expanded 110 basis points quarter over quarter, but operating margin compressed 180 basis points and EBITDA margin compressed 130 basis points; a roughly $16 million one-time tariff refund helped the top of the margin statement. Management's H2 plan is volume-led, with pricing moderating but still at or above the high end of the 100–200 bps range.
The Model
The model projects FY+1 revenue of $5,863 million and EBITDA of $1,466 million (25.0% margin), and FY+2 revenue of $6,137 million and EBITDA of $1,596 million (26.0% margin). Near-term revenue is anchored by the H2 2026 core growth guide of approximately 5%–6%, while FY+2 margin expansion reflects the cost optimization savings ramp toward $65–$75 million in annual savings by 2028.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $5.5B | $5.9B | $6.1B |
| YoY Growth | — | +6.5% | +4.7% |
| EBITDA | $1.4B | $1.5B | $1.6B |
| EBITDA Margin | 24.6% | 25.0% | 26.0% |
Projections are the median of 5 independent model runs. The model’s revenue sits 0.6% below analyst consensus.
For FY2026, management raised adjusted EPS guidance to $4.35–$4.43, representing 12%–14% growth. H2 core sales growth is guided to approximately 5%–6%, volume-led, with pricing at or slightly above the high end of the 100–200 bps range. Margin expansion is guided to roughly 25 bps in Q3, 25–50 bps for the full year, and north of 50 bps in Q4 led by PQI. No further tariff refunds are included in H2 guidance.
What Could Go Right — and Wrong
- Data-center/AI water revenue becomes large enough for management to disclose, converting a small unquantified tailwind into a forecastable line.
- Cost optimization reaches its $65–$75 million annual savings run-rate by 2028, adding to the 30–35% fall-through.
- PQI digital workflow and AI adoption lift software mix, segment margin, and recurring revenue.
- China municipal water funding releases and high-growth markets reaccelerate, removing a regional drag.
- Trojan UV backlog converts to shipments in Q4 2027, extending Water Quality growth.
- H2 2026 volume-led core growth of 5%–6% fails because improvement is comp-driven rather than demand-driven.
- PQI packaging and color recovery stalls, pressuring the Q4 margin step-up and H2 acceleration.
- ChemTreat raw-material costs outrun pricing, compressing margins in the fastest-growing water franchise.
- Cost optimization restructuring disrupts operations or customer-facing execution through 2028.
- Sole/limited-source component supply interruptions are slow to remedy, hitting production.
Looking Ahead
The next 12 months test the volume-led H2 2026 core growth plan, a Q4 2026 margin step-up north of 50 basis points, and the first small cost-savings lift in Q4 2026. Into 2027, the focus shifts to the cost program's roughly 50% run-rate savings, Trojan UV shipments largely in Q4 2027, and whether data-center-linked water demand becomes a disclosed, material line.
- Q3 2026Q3 2026 earnings — Tests H2 core sales growth of ~5%–6% and Q3 margin expansion of ~25 bps.
- Q4 2026Q4 margin step-up — Tests guided Q4 adjusted operating margin expansion north of 50 bps, led by PQI.
- Q4 2026Cost program first savings — Small Q4 2026 benefit of a few million dollars; biggest benefit expected in 2027.
- FY 2026Full-year EPS delivery — Tests adjusted EPS of $4.35–$4.43, representing 12%–14% growth.
- 2027Cost program ~50% run-rate — Tests roughly 50% of run-rate savings in 2027 and the step-change algorithm.
- Q4 2027Trojan UV shipment conversion — Tests long-cycle Trojan bookings expected to ship largely in Q4 2027.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $5.2B | $5.5B | $5.7B | +6.0% |
| Gross Margin | 59.6% | 60.0% | 60.2% | +33bps |
| EBITDA | $1.3B | $1.4B | $5.7B | +5.4% |
| EBITDA Margin | 24.8% | 24.6% | 24.1% | 14bps |
| Net Income | $833M | $940M | $988M | +12.8% |
| Free Cash Flow | $820M | $1.0B | $4.1B | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)60.2%
- EBITDA Margin (TTM)24.1%
- Net Margin (TTM)17.3%
- ROIC23.5%
- FCF Conversion76.1%
- SBC / Revenue1.3%
The Company
Veralto makes water-quality testing, treatment, and disinfection systems plus product-inspection and packaging technologies. Water Quality includes Hach, Trojan Technologies, and ChemTreat; Product Quality & Innovation includes Videojet, Esko, X-Rite, Pantone, and GlobalVision. These products sit inside customer operations where failure is expensive—water plants that must keep treating water and brand owners that cannot tolerate labeling or product-safety errors.
The company has 17,000 associates and 60 total facilities, including 21 in the United States across 12 states and 39 outside the U.S., primarily in Europe. It operates a Danaher-style continuous-improvement playbook and has accelerated bolt-on M&A, adding In-Situ, GlobalVision, and Alfaa UV in 2026.
Business Segments
Competitive Landscape
Only Dover Corporation is documented as a direct competitor; Dover's own filing names Veralto (Videojet). Ecolab, Xylem, Mettler-Toledo, and Solenis are inferred competitors from the supply-chain map. Management frames Veralto's edge as embedded products in customer operations with high cost-of-failure, not pricing.
- Dover CorporationDocumented competitor in imaging and identification / marking and coding; Dover's disclosure names Veralto Corporation (Videojet).
- EcolabInferred competitor in industrial water treatment chemicals and data-center cooling.
- XylemInferred competitor in water analytics and UV disinfection; also appears as a supplier in the generated map.
- Mettler-ToledoInferred competitor in ultrapure water analytics.
- SolenisInferred competitor in industrial water treatment chemicals.
Supply Chain
Veralto sits between component suppliers, contract manufacturers, and a broad installed base of municipal, industrial, and brand-owner customers. No neighbor transcript directly named Veralto; only Dover appears as a documented counterparty.
More on VLTO: Earnings recap